First Trust Nasdaq Pharmaceuticals ETF (FTXH)
First Trust Nasdaq Pharmaceuticals ETF operates in the Asset Management - Global industry of the Financial Services sector, headquartered in Wheaton, IL, US. The stock last traded at $41.67, up 0.24% on the session, giving a market capitalisation of $1.03B. Its beta of 0.46 implies it has historically moved less than the broad market.
The First Trust Nasdaq Pharmaceuticals ETF (FTXH) operates as an exchange-traded fund. Its primary aim is to mirror the financial performance—both capital appreciation and income generation—of the Nasdaq US Smart Pharmaceuticals Index, prior to any fund-specific fees and expenses. To achieve this, the ETF endeavors to precisely replicate the constituents and their proportionate allocations within that index, striving for a performance correlation of at least 95%.
First Trust Nasdaq Pharmaceuticals ETF is most often compared with the following Financial Services names: